Department of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan,
World J Pediatr. 2015 Feb;11(1):21-8. doi: 10.1007/s12519-015-0003-9. Epub 2015 Jan 28.
Nephrotic syndrome is the most common cause of kidney disease in children, but its pathogenesis remains unclear. This article reviews the novel aspects of the mechanisms underlying massive proteinuria in minimal-change disease, which is the most common form of childhood nephrotic syndrome.
This article integrates the findings of a PubMed database search for English language articles published in the past 40 years (from September 1974 to February 2014) using the key words "pathogenesis", "minimal change nephrotic syndrome" or "idiopathic nephrotic syndrome".
Unknown humoral factors associated with T-cell dysfunction have been thought to play an important role in the pathogenesis of minimal-change disease. However, recent findings are changing this paradigm, i.e., visceral glomerular epithelial cells (podocytes) may be involved via expression of molecules such as CD80 and angiopoietin-like 4.
Recent evidence suggests that minimal-change disease results from interactions between humoral factors and dysfunctional podocytes. In addition to immunosuppressant drugs that target lymphocytes, a biological agent such as an antibody against the abnormal molecule(s) expressed by podocytes may provide novel drug treatment for minimal-change disease.
肾病综合征是儿童最常见的肾脏疾病病因,但发病机制仍不清楚。本文综述了微小病变肾病大量蛋白尿发病机制的新方面,微小病变肾病是儿童肾病综合征最常见的类型。
本文综合了利用关键词“发病机制”、“微小病变肾病”或“特发性肾病综合征”,对过去 40 年(1974 年 9 月至 2014 年 2 月)发表的英文文献在 PubMed 数据库中的搜索结果。
与 T 细胞功能障碍相关的未知体液因子被认为在微小病变病的发病机制中发挥重要作用。然而,最近的发现正在改变这一模式,即内脏肾小球上皮细胞(足细胞)可能通过表达 CD80 和血管生成素样 4 等分子而受累。
最近的证据表明,微小病变病是由体液因子与功能失调的足细胞之间的相互作用引起的。除了针对淋巴细胞的免疫抑制剂药物外,针对足细胞表达的异常分子的生物制剂(如针对异常分子的抗体)可能为微小病变病提供新的药物治疗。